AJCC

AJCC stands for the American Joint Committee on Cancer, the organization that publishes the staging system used by doctors in the United States to describe how far a cancer has spread. For pleural mesothelioma and other asbestos-related cancers, the AJCC TNM staging system (Tumor, Node, Metastasis) is the standard tool oncologists use to assign a stage from I to IV. The staging directly influences treatment options, eligibility for surgery or clinical trials, and prognosis.

Origin

The American Joint Committee on Cancer was founded in 1959 as the American Joint Committee for Cancer Staging and End Results Reporting, organized by the American College of Surgeons and other medical societies. It published its first Staging Manual in 1977 and has since released regular updates; the 8th edition (effective 2018) introduced significant revisions to pleural mesothelioma staging based on data from the International Association for the Study of Lung Cancer (IASLC).

Significance in Asbestos Context

For patients with mesothelioma or asbestos-related lung cancer, the AJCC stage written in the pathology or oncology report drives nearly every major decision: whether surgery (such as pleurectomy/decortication or extrapleural pneumonectomy) is offered, what chemotherapy or immunotherapy regimens apply, and which clinical trials a patient can enter. The stage also becomes critical evidence in a legal claim, because damages, life expectancy projections, and settlement valuations are tied to disease severity. Defense experts sometimes dispute staging or argue that a different stage applies, so the precise AJCC stage and edition used should be clearly documented in medical records.

Example Sentence

The oncologist explained that under the AJCC 8th edition, her husband's pleural mesothelioma was classified as stage III, which made him a candidate for multimodal therapy but not curative surgery.

Related Terms

TNM Staging, Pleural Mesothelioma, Prognosis, IASLC, Pathology Report, Clinical Trial

Notes

• Ask your oncologist which edition of the AJCC manual (currently the 8th) was used to stage your disease and request that the full TNM designation (e.g., T2 N1 M0) appear in your records.
• Keep copies of every staging document (imaging reports, pathology reports, and oncology notes) because stage at diagnosis is a key factor in both treatment planning and legal damages.
• If you are considering a second opinion at a mesothelioma specialty center, bring all original imaging on disc; restaging by an experienced team sometimes changes treatment eligibility.
• For pleural mesothelioma specifically, ask whether you have been evaluated against IASLC staging data, since the AJCC system for this disease is built on IASLC research and specialists often reference both.